MTOR and cardiac hypertrophy: mTOR was found to be linked to isoprenaline-induced cardiac hypertrophy pathogenesis (Zhang et al., 2015) [47], and several studies defined the hyperactivation of mTOR as a critical mediator of DM pathophysiology by enhancing insulin resistance and inflammation.